Jean-Charles Soria
Chief Tech/Sci/R&D Officer bei AMGEN INC.
Profil
Jean-Charles Soria is the founder of Gritstone bio, Inc. (founded in 2015).
He is currently the Director-General at Institut Gustave Roussy EURL since 2017, the SVP-Research and Development at Amgen, Inc., and a Professor at Université Paris-Saclay.
His former positions include being an Independent Director at HOOKIPA Pharma, Inc., Senior Vice President at MedImmune LLC and AstraZeneca PLC (2017-2019), a Member-Supervisory Board at Innate Pharma SA (2017), and an Associate Professor at The University of Texas M.D.
Anderson Cancer Center (2013-2017).
He also served as the Senior VP-Oncology Research & Development at AstraZeneca US from 2017 to 2019.
Aktive Positionen von Jean-Charles Soria
| Unternehmen | Position | Beginn |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
Institut Gustave Roussy EURL
 Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Corporate Officer/Principal | 01.01.2001 |
| Université Paris-Saclay | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jean-Charles Soria
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2019 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2019 |
| AstraZeneca US | Chief Tech/Sci/R&D Officer | 01.01.2019 |
| INNATE PHARMA | Director/Board Member | 30.08.2017 |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01.01.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| INNATE PHARMA | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| HOOKIPA PHARMA INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Institut Gustave Roussy EURL
Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Commercial Services |
| AstraZeneca US |
